Aspen Online Webinar July  14-16, 2020

What’s Hot? NAFLD and NASH Stavra Xanthakos

• Fatty liver disease burden of NAFLD and NASH is increasing.  This increases the rate of cirrhosis, liver cancer and liver transplantation; the latter is being needed at younger ages
• Explained that “Lean” (normal BMI) NAFLD is common
• Diabetes is strongest risk factor for severe fatty liver disease (NASH or fibrosis). PNPLA3 is genetic risk factor for NAFLD risk.
• Discussed treatment, particularly diet  and bariatric surgery.  Stated that some emerging treatments look promising.
• In those with suspected NAFLD, Dr. Xanthokos recommends liver biopsy, if lifestyle therapy is ineffective, under specific circumstances: prior to bariatric surgery, in some cases to determine severity, and prior to instituting therapy (eg Vitamin E)

Related blog posts:

• The Paramount Health Challenge for Humans in the 21st Century
• How Often Do Children with Obesity Have a Fatty Liver?
• Pediatric NAFLD: You Don’t Have to be Obese/Overweight to have Fatty Liver Disease (but it helps)
• Should Teenagers with Severe NAFLD Undergo Bariatric Surgery?
• Concise Review: Fatty Liver in Pediatrics
• Reaching Consensus on Bariatric Intervention in Children …
• Is a Three Year-Old Too Young for Bariatric Surgery …
• Should We Be Excited About a New Medication (Liraglutide …
• Overlooking Obesity in Hospitalized Children | gutsandgrowth
• Treating diabetes with surgery | gutsandgrowth